Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-18T04:37:19.805Z Has data issue: false hasContentIssue false

Shall we really say goodbye to first rank symptoms?

Published online by Cambridge University Press:  23 March 2020

A. Heinz
Affiliation:
Department of Psychiatry and Psychotherapy, Charité University Medicine, Saint-Hedwig Hospital, Humboldt University, Berlin, Germany
M. Voss*
Affiliation:
Department of Psychiatry and Psychotherapy, Charité University Medicine, Saint-Hedwig Hospital, Humboldt University, Berlin, Germany
S.M. Lawrie
Affiliation:
Division of Psychiatry, University of Edinburgh, Kennedy Tower, Royal Edinburgh Hospital, EdinburghEH10 5HF, UK
A. Mishara
Affiliation:
Department of Clinical Psychology, Chicago School of Professional Psychology, Los Angeles, USA
M. Bauer
Affiliation:
University Hospital Carl Gustav Carus, Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany
J. Gallinat
Affiliation:
University Clinic Hamburg-Eppendorf, Clinic and Policlinic for Psychiatry and Psychotherapy, Hamburg, Germany
G. Juckel
Affiliation:
Department of Psychiatry, Psychotherapy, and Psychosomatic Medicine, Ruhr-University, Bochum, Germany
U. Lang
Affiliation:
Psychiatric University Clinics (UPK), Basel, Switzerland
M. Rapp
Affiliation:
Social and Preventive Medicine, University of Potsdam, Potsdam, Germany
P. Falkai
Affiliation:
Department of Psychiatry and Psychotherapy, Ludwig-Maximilians University, Munich, Germany
W. Strik
Affiliation:
University Hospital of Psychiatry, University of Bern, Bern, Switzerland
J. Krystal
Affiliation:
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
A. Abi-Dargham
Affiliation:
Department of Psychiatry, Columbia University, New York, NY, USA
S. Galderisi
Affiliation:
Department of Psychiatry, University of Naples SUN, Naples, Italy
*
* Corresponding author. Department of Psychiatry and Psychotherapy, Charite´ University Medicine, Saint-Hedwig Hospital, Große Hamburger Str. 5-11, 10115 Berlin, Germany.E-mail address:martin.voss@charite.dez (M. Voss).
Get access

Abstract

Background

First rank symptoms (FRS) of schizophrenia have been used for decades for diagnostic purposes. In the new version of the DSM-5, the American Psychiatric Association (APA) has abolished any further reference to FRS of schizophrenia and treats them like any other “criterion A” symptom (e.g. any kind of hallucination or delusion) with regard to their diagnostic implication. The ICD-10 is currently under revision and may follow suit. In this review, we discuss central points of criticism that are directed against the continuous use of first rank symptoms (FRS) to diagnose schizophrenia.

Methods

We describe the specific circumstances in which Schneider articulated his approach to schizophrenia diagnosis and discuss the relevance of his approach today. Further, we discuss anthropological and phenomenological aspects of FRS and highlight the importance of self-disorder (as part of FRS) for the diagnosis of schizophrenia. Finally, we will conclude by suggesting that the theory and rationale behind the definition of FRS is still important for psychopathological as well as neurobiological approaches today.

Results

Results of a pivotal meta-analysis and other studies show relatively poor sensitivity, yet relatively high specificity for FRS as diagnostic marker for schizophrenia. Several methodological issues impede a systematic assessment of the usefulness of FRS in the diagnosis of schizophrenia. However, there is good evidence that FRS may still be useful to differentiate schizophrenia from somatic causes of psychotic states. This may be particularly important in countries or situations with little access to other diagnostic tests. FRS may thus still represent a useful aid for clinicians in the diagnostic process.

Conclusion

In conclusion, we suggest to continue a tradition of careful clinical observation and fine-grained psychopathological assessment, including a focus on symptoms regarding self-disorders, which reflects a key aspect of psychosis. We suggest that the importance of FRS may indeed be scaled down to a degree that the occurrence of a single FRS alone should not suffice to diagnose schizophrenia, but, on the other hand, absence of FRS should be regarded as a warning sign that the diagnosis of schizophrenia or schizoaffective disorder is not warranted and requires specific care to rule out other causes, particularly neurological and other somatic disorders. With respect to the current stage of the development of ICD-11, we appreciate the fact that self-disorders are explicitly mentioned (and distinguished from delusions) in the list of mandatory symptoms but still feel that delusional perceptions and complex hallucinations as defined by Schneider should be distinguished from delusions or hallucinations of “any kind”. Finally, we encourage future research to explore the psychopathological context and the neurobiological correlates of self-disorders as a potential phenotypic trait marker of schizophrenia.

Information

Type
Review
Copyright
Copyright © European Psychiatric Association 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Submit a response

Comments

No Comments have been published for this article.